Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
6,930
+240
+4% +$51.6K 0.24% 103
2026
Q1
$1.46M Buy
6,690
+213
+3% +$47.2K 0.23% 110
2025
Q4
$1.44M Buy
6,477
+1,700
+36% +$387K 0.22% 103
2025
Q3
$1.11M Buy
4,777
+55
+1% +$11.2K 0.18% 129
2025
Q2
$894K Sell
4,722
-96
-2% -$17.8K 0.16% 145
2025
Q1
$931K Buy
4,818
+418
+10% +$81.3K 0.18% 128
2024
Q4
$797K Buy
4,400
+159
+4% +$29.2K 0.17% 121
2024
Q3
$837K Sell
4,241
-6
-0.1% -$1.12K 0.19% 109
2024
Q2
$710K Buy
4,247
+77
+2% +$12.8K 0.17% 122
2024
Q1
$754K Sell
4,170
-1
-0% -$172 0.21% 106
2023
Q4
$667K Sell
4,171
-907
-18% -$132K 0.2% 126
2023
Q3
$749K Buy
5,078
+501
+11% +$73.5K 0.23% 109
2023
Q2
$620K Sell
4,577
-85
-2% -$12.5K 0.24% 97
2023
Q1
$752K Buy
4,662
+193
+4% +$29.5K 0.31% 80
2022
Q4
$655K Buy
4,469
+832
+23% +$128K 0.27% 97
2022
Q3
$503K Buy
3,637
+133
+4% +$19.1K 0.4% 73
2022
Q2
$533K Buy
3,504
+124
+4% +$18.9K 0.44% 66
2022
Q1
$524K Buy
3,380
+416
+14% +$60.4K 0.35% 81
2021
Q4
$404K Buy
+2,964
New +$350K 0.26% 108

Other funds holding ABBV

Ignite Planners's ABBV Position: Q2 2026 in Review

Ignite Planners increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $51.6K and bringing the position to 6,930 shares worth $1.74M. The position accounts for 0.24% of the portfolio, ranked #103.

Ignite Planners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ignite Planners held 6,930 shares of AbbVie worth $1.74M as of Q2 2026.
  • Ignite Planners bought 240 AbbVie shares in Q2 2026, an estimated $51.6K.
  • AbbVie made up 0.24% of Ignite Planners's portfolio in Q2 2026, its #103 holding.
  • Ignite Planners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.